News Focus
News Focus
Followers 22
Posts 2254
Boards Moderated 0
Alias Born 06/08/2017

Re: dennisdave post# 534473

Thursday, 11/17/2022 6:28:25 PM

Thursday, November 17, 2022 6:28:25 PM

Post# of 828926
MIC DROP - FDA approves drugs all the time based on just single Arm studies without a control group for improvements much less than survival benefit at 5 years. The fact that we have so many patients alive at 5 years (real GBM patients, the new definition) when most doctors know how unlikely this is in real life. Below is an example, I can post countless others. So stop your yapping.

"The approval itself was based on a single-arm study showing an overall response rate of 31.7% in 106 ovarian cancer patients who’d received between one to three previous systemic treatments. Researchers saw five patients achieve a complete response and a median duration of response of 6.9 months."

https://endpts.com/fda-bestows-accelerated-approval-on-immunogens-ovarian-cancer-drug-with-confirmatory-answer-coming-soon/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News